Research Rounds

Join us for the Gynecologic Cancer Initiative Research Rounds! The Gynecologic Cancer Initiative Research Rounds features researchers working on accelerating transformative research on prevention, treatment and survivorship of gynecologic cancers. The goal of these research rounds is to provide a forum for researchers, trainees and staff to learn about the range of different gynecologic cancer research projects happening across British Columbia. All researchers, clinicians, trainees, and staff members are welcome to join!

Please note that you must register to attend these research rounds. Meeting details will be sent out to registrants before the event. Light refreshments will be provided to in-person attendees!

2023 – 2024 Research Rounds

February 6, 2024

Leveraging array-based DNA methylation analysis for gynecologic cancer research and diagnostics

Dr. Felix Kommoss

January 29, 2024

Striving for a better understanding of vulvar cancer

Dr. Lois Eva

January 26, 2024

Real-world experiences of first-line maintenance PARP inhibitor treatment in non-BRCA mutant high-grade serous ovarian cancer

Dr. Nicola Hannaway

December 8, 2023

Discovery of HPV-Associated Genomic Alterations in Cervical Cancer

Vanessa Porter

November 24th, 2023

Exploring the Full Potential of PARP Inhibitors in Ovarian Cancer, and Other Pursuits of the Clinical Researcher

Dr. Anna Tinker

November 10th, 2023

Peritumoral Stromal Remodelling and Ontogenetic Spread of Uterine Cervical Cancer

Dr. Lars-Christian Horn

October 16, 2023

From Atypical Hyperplasia to Endometrial Carcinoma: Unravelling Molecular Subtypes and Histological Transformations

Dr. Jutta Huvila

September 29, 2023

Telomerase non-canonical function in DNA damage response in the context of high-grade serous ovarian cancer

Kat Nguyen

2022 – 2023 Research Rounds

May 26, 2023 | 12 – 1pm PST

Pathology AI in Gynecological Cancers: Current Advances and Future Directions

Dr. Ali Bashashati

April 14, 2023

The continuing evolution of endometrial carcinoma molecular classification

Dr. Amy Jamieson

March 31, 2023

Opportunistic salpingectomy during caesarean section: Detailing the safety to improve uptake of OS for sterilization

Dr. Gillian Hanley & Khaye Rufin

February 17, 2023

Defining targetable vulnerabilities in small cell carcinoma of the ovary hypercalcemic type: a journey from genomic discovery to therapeutic development

Dr. Yemin Wang

January 27, 2023

Evaluating patient adherence, satisfaction and out-of-pocket expense following implementation of offering an oral option for post-operative venous thromboembolic prophylaxis after Gynecologic Oncology surgery

Dr. Kimberly Stewart

December 9, 2022

Clinical phenotyping of KRAS somatic mutations in endometriosis

Dr. Paul Yong

November 18, 2022

Podocalyxin in High Grade Serous Ovarian Carcinoma

Dr. Calvin Roskelley

October 28, 2022

Long Term Colposcopy Referral Rates after the Introduction of HPV-based Cervix Screening

Dr. Anna Gottschlich

2021-2022 Research Rounds Recordings

Targeting the DNA damage response in gynaecological cancers beyond PARP inhibitors

Dr. Yvette Drew

Deciphering and re-engineering the immune response to gynecological cancers

Dr. Brad Nelson

Genetic testing initiatives in ovarian cancer

Dr. Janice Kwon

Cultural safety in reproductive health and being an ally

Dr. Unjali Malhotra

Application of machine learning to predict recurrence in high grade endometrial cancer

Dr. Sabrina Piedimonte

Vulvar cancer: more than meets
the eye

Dr. Lynn Hoang

Is Worldview a Cervical Cancer Risk?: Challenging Settler Paradigms for Indigenous Health Research

Dr. Sheona Mitchell-Foster

The Value and impact of supportive cancer care

Dr. Hannah Nette

The ELECTRA journey – The challenges of bringing molecular classification of endometrial carcinoma into routine diagnostic practice

Dr. Naveena Singh

How to address frailty and low physical function in women with early stage and advanced cancers

Dr. Kristen Campbell

Dr. Kristen Campbell

Therapeutic advancement and biomarker discovery in women’s cancers: Research models and strategies

Dr. Mark Carey

Dr. Mark Carey

Advances in interstitial gyne brachytherapy in BC

Dr. Francois Bachand

Dr. Francois Bachand

2020-2021 Research Rounds Recordings

Drugs targeting to tumors in the peritoneal cavity

Dr. Shyh-Dar Li, PhD

Hereditary gynceologic cancers: testing, prevention and management

Dr. Lesa Dawson, MD, FRCSC

Metabolism, cancer and the immune system – what do they have in common?

Dr. Julian Lum, PhD

Heterogeneity and molecular subtypes in endometriosis-associated cancers and their precursors

Dr. Michael Anglesio, PhD

Strategies for making an impact with policy makers: Methods from women’s health research

Dr. Sarah Munro, PhD

What’s new in the classification of gynecological cancers: the 5th edition of the WHO guidelines

Dr. Blake Gilks, MD

Clinical prediction
models in
gynecological oncology

Dr. Aline Talhouk, PhD

Real-life patient
experiences in
gynecologic oncology

Dr. Jenny Ko, MD

Where are the knowledge gaps to get us to cervical cancer elimination in women living with HIV?

Dr. Deborah Money, MD  Dr. Elisabeth McClymont, PhD

Opportunistic salpingectomy for ovarian cancer prevention and age of onset of menopause: Reassuring findings from British Columbia

Dr. Gillian Hanley, PhD

New data on POLEmut and NSMMP molecular subtypes of endometrial cancer and how molecular classification is changing EC management today

Dr. Jessica McAlpine, MD

Ovarian cancer subtypes reframed as distinct oncogenic journeys: a post-genomic approach to research

Dr. David Huntsman, MD